====== Qu Biologics ====== {{ :pharmaceutical_companies:qu_biologics_logo_.png?200|}} **Qu Biologics, Inc.** is a Canadian biotechnology company based in [[:canada:british_columbia:Burnaby]], [[:canada:British Columbia]]. ===== History ===== Qu Biologics was founded in 2007 by [[:Hal Gunn]] and [[:Rob Freeman]].((//Our History.// Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/)) ===== Organization ===== Qu Biologics is a member organization of the [[:Biotechnology Innovation Organization]] (BIO) and [[:N2 Canada]].((//BIO Member Directory.// Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory)) ((//Members.// N2 Canada. Retrieved October 11, 2022, from http://archive.today/2022.10.11-054124/https://n2canada.ca/members/)) ==== Personnel ==== ^ Qu Biologicals - Team((//Management Team.// Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved February 18, 2015, from http://archive.today/2015.02.18-140801/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics Inc. Retrieved October 1, 2016, from http://archive.today/2016.10.01-094757/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved April 15, 2017, from http://archive.today/2017.04.15-053456/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved April 19, 2018, from http://archive.today/2018.04.19-170653/http://www.qubiologics.com/who-we-are/management-team/)) ^^^ ^ Name ^ Position ^ Notes ^ | [[:Hal Gunn]] | CEO and Founder | [[:InspireHealth]], [[:University of British Columbia]] (UBC) | | [[:Simon Sutcliffe]] | Chief Medical Officer - Oncology | [[:Ontario Cancer Institute]], [[:Princess Margaret Hospital]], [[:BC Cancer Agency]], [[:Canadian Strategy for Cancer Control]], [[:Canadian Partnership Against Cancer]], [[:Canadian Cancer Society]], [[:National Medical Advisory Committee]], [[:Michael Smith Foundation for Health Research]] (MSFHR), [[:Genome British Columbia]], [[:International Cancer Control Congress]] (ICCC), [[:Two Worlds Cancer Collaboration]], [[:Premier Diagnostic Centre]], [[:Premier Diversified Holdings]] (PDH), [[:InspireHealth]], [[:Institute for Health Systems Transformation & Sustainability]] (IHSTS), [[:Terry Fox Research Institute]] (TFRI) | | [[:Ted Steiner]] | Chief Medical Officer - Infectious Diseases | [[:University of British Columbia]], [[:Vancouver General Hospital]] (VGH), [[:BC Children's Hospital Research Institute]], [[:Canadian Institutes of Health Research]] (CIHR), [[:Crohn's & Colitis Canada]], [[Merck]], [[:COVID-19 Immunity Task Force]] (CITF), [[:Vancouver Coastal Health Research Institute]] (VCHRI), [[:COVID-19 Clinical Research Coordination Initiative]] (CRCI) | | [[:Matt Cahill]] | Chief Operating Officer | [[:Deep Genomics]], [[:University of Toronto]] | | [[:Shirin Kalyan]] | Vice President, Scientific Innovation | [[:Alexander von Humboldt Foundation]], [[:University of British Columbia]] | | [[:David Mullins]] | Chief Scientific Officer (former) | [[:Norris Cotton Cancer Center]], [[:Society for the Biological Therapy of Cancer]], [[:American Association of Immunologists]] | | [[:Gillian Vandermeirsch]] | Vice President of Operations (former) | [[:Pasteur Institute]], [[Augurex]], [[:University of British Columbia]] | | [[:Bob Cory]] | Vice President of Business Development (former) | [[Bioasis Technologies]], [[MIGENIX]], [[Illumigen Biosciences]] | | [[:Julie Jang]] | Director of Communications (former) | [[Sirona Biochem]], [[Zalicus]], [[:CityNews 1130]], [[:Global Television Network]], [[:CTV]] | | [[:Heidi Biagi]] | Director of Project Management (former) | [[Novadeq Technologies]], [[QLT]] | | [[:Russell McAllister]] | Vice President of Finance (former) | [[Lakewood-Amedex]], [[:H.C. Wainwright & Co.]], [[Thomas Weisel Partners]], [[Merriman Curhan Ford & Co.]], [[PricewaterhouseCoopers]] | | [[:Jim Pankovich]] | Vice President of Clinical Operations & Drug Development (former) | [[:CIHR Canadian HIV Trials Network]] (CTN), [[MIGENIX]], [[Inex Pharmaceuticals]], [[CV Technologies]] | | [[:Kevin Harper]] | Acting Director of Manufacturing (former) | [[:HH Consultancy]], [[Sanofi Pasteur]], [[Novartis]] | | [[:Nicole Clendinning]] | Director of Finance (former) | [[:Chartered Professional Accountant of British Columbia]] | | [[:Alun Rees]] | Vice President of Manufacturing (former) | [[STEMCELL Technologies]], [[QLT]], [[GlaxoSmithKline]], [[Bio Products Laboratories]] (BPL) | | [[:Mark Bazett]] (former) | Director of Preclinical and Translational Research | [[:Meakins-Christie Laboratories]] | ^ Board of Directors((//Board of Directors.// Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502044842/https://www.qubiologics.com/who-we-are/board-of-directors/)) ^^^ | [[:Julia Levy]] | Board member | [[QLT]], [[:Foundation Fighting Blindness]], [[:Wilmer Eye Institute]], [[:Life Sciences British Columbia]], [[:University of British Columbia]] | | [[:Karn Manhas]] | Board member | [[:Terramera]], [[:Young Presidents' Organization]] (YPO), [[:Unreasonable Group]] | | [[:Mile Leschuk]] | Board member | [[:Leschuk-Weisz Developments]], [[:Rob Freeman Foundation]], [[:PricewaterhouseCoopers]], [[:London Telecom Group]] | | [[:Foster Coulson]] | Board member | [[:Integro Cap]] | | [[:Marc Lambiotte]] | Board member | [[:West Coast General Hospital]] | ^ Scientific Advisory Board((//Scientific Advisory Board.// Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507165939/https://www.qubiologics.com/who-we-are/scientific-advisory-board/)) ^^^ | [[:Dieter Kabelitz]] | Scientific Advisor | [[:University of Kiel]], [[:German Society of Immunology]], [[:International Union of Immunological Societies]], [[:Rockefeller University]], [[:University of Heidelberg]], [[:Paul Ehrlich Institute]], [[:SFB 1315]], [[:Cluster of Excellence Inflammation at Interfaces]] | | [[:Bruce Vallance]] | Scientific Advisor | [[:Child & Family Research Institute]] (CFRI), [[:Crohn’s and Colitis Canada]], [[:CH.I.L.D. Foundation]], [[:BC Children's Hospital]], [[:University of British Columbia]] (UBC) | | [[:Balfour Sartor]] | Scientific Advisor | [[:University of North Carolina at Chapel Hill]], [[:National Gnotobiotic Rodent Resource Center]], [[:Crohn's & Colitis Foundation]] | | [[:Michael Noble]] | Scientific Advisor | [[:University of British Columbia]] | | [[:Robert E.W. Hancock]] | Scientific Advisor | [[:University of British Columbia]], [[:R.E.W. Hancock Laboratory]], [[MIGENIX]], [[Inimex Pharmaceuticals]], [[ABT Innovations]], [[Sepset Biotherapeutics]], [[:Centre for Drug Research and Development]] (CDRD) | ^ IBD Clinical Advisors((//IBD Clinical Advisors.// Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507171856/https://www.qubiologics.com/who-we-are/clinical-advisors/)) ^^^ | [[:Brian Feagan]] | Clinical Advisor | [[:Schulich School of Medicine & Dentistry]], [[:London Health Sciences Centre]], [[:Robarts Research Institute]] | | [[:William Sandborn]] | Clinical Advisor | [[:University of California San Diego]], [[:UC San Diego Health System]], [[:Mayo Clinic]] | | [[:Brian Bressler]] | Clinical Advisor | [[:University of British Columbia]], [[:Massachusetts General Hospital]], [[:Harvard Medical School]] | | [[:John Marshall]] | Clinical Advisor | [[:McMaster University]], [[:Hamilton Health Sciences]], [[:Farncombe Family Digestive Health Research Institute]], [[:Canadian Association of Gastroenterology]], [[:American Gastroenterological Association]] | ==== Funding ==== Since 2007, Qu Biologics has "raised over CAD$40 million in funding from private investors and government funding".((//Our History.// Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/)) The company has received grants and investment funding from:((//Qu Biologics Inc. - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved May 1, 2023, from https://www.crunchbase.com/organization/qu-biologics-inc/company_financials)) ((//Portfolio.// ACA Group. Retrieved May 1, 2023, from http://archive.today/2023.05.01-212531/https://aca-investments.com/portfolio/)) * [[:Asian Capital Alliance]] (ACA Group) * [[:Harmonix Fund]] * [[:National Research Council of Canada]] [[:National Research Council of Canada Industrial Research Assistance Program|Industrial Research Assistance Program]] (NRC IRAP) ===== External links ===== * [[https://www.crunchbase.com/organization/qu-biologics-inc|Crunchbase]] * [[https://www.linkedin.com/company/qu-biologics-inc/|LinkedIn]] * [[https://www.qubiologics.com/|Website]] * [[https://wiki.whiteroseintelligence.com/en/Qu-Biologics|White Rose Wiki]]